Workflow
Ultralife(ULBI)
icon
Search documents
Ultralife Corporation Added to Russell 2000® Index
Newsfilter· 2024-07-01 11:00
Core Insights - Ultralife Corporation has been included in the Russell 2000® Index and the broader Russell 3000® Index, indicating a significant enhancement in its financial profile and earnings potential as a result of successful new product investments and margin recovery [1][4]. Company Overview - Ultralife Corporation is headquartered in Newark, New York, and operates in two main business segments: Battery & Energy Products and Communications Systems. The company has a global presence with operations in North America, Europe, and Asia [2][5]. Index Inclusion Details - The annual reconstitution of the Russell U.S. Indexes, effective July 1, 2024, identified Ultralife among the 4,000 largest U.S. stocks based on total market capitalization. This inclusion in the Russell 3000® Index also secures its position in the small-cap Russell 2000® Index and relevant growth and value style indexes [3][4]. Market Impact - The inclusion in the Russell Index is expected to increase Ultralife's visibility among institutional investors who are interested in companies operating in the expanding markets for power solutions and electronic systems, thereby contributing to shareholder value through sustainable and profitable growth [1][4].
Ultralife Corporation Is Attractive Here
Seeking Alpha· 2024-06-30 15:14
Business Overview Performance, Safety and Reliability for Their Critical Applications Revenue Mix TTM by Revenues TTM by Business Segment Market Segment ent & Defense I Battery & Energy Products #Communications Systems Safety & Security & Industrial Medical & Healthcare Energy Storage Oll & Gas and SubSea History & Background Founded in 1991; NASDAQ - ULBI Headquarters - Newark, NY Employees – 545 Business Segments: Battery & Energy Products Communications Systems Strategic Business Locations in N. America, ...
Ultralife(ULBI) - 2024 Q1 - Earnings Call Transcript
2024-04-27 12:15
Ultralife Corporation (NASDAQ:ULBI) Q1 2024 Earnings Call Transcript April 25, 2024 8:30 AM ET Company Participants Jody Burfening - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Samuel McColgan - Breakout Investors Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a q ...
Ultralife(ULBI) - 2024 Q1 - Quarterly Report
2024-04-25 11:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or o ...
Ultralife(ULBI) - 2024 Q1 - Quarterly Results
2024-04-25 11:30
Exhibit 99.1 Ultralife Corporation Reports First Quarter Results NEWARK, N.Y. – April 25, 2024 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights: "Ultralife's strong first quarter results are a testament to the teamwork and success to date of our gross margin improvement initiatives and continued demand in our core products, particularly from our government/defense and medical customers," said Mike Manna, President and ...
Ultralife(ULBI) - 2023 Q4 - Annual Report
2024-03-21 20:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other ...
Ultralife(ULBI) - 2023 Q4 - Earnings Call Transcript
2024-02-15 20:52
Ultralife Corporation (NASDAQ:ULBI) Q4 2023 Earnings Call Transcript February 15, 2024 8:30 AM ET Company Participants Jody Burfening - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Brett Davidson - Investletter John Deysher - Pinnacle Operator Thank you for standing by, and welcome to Ultralife Corporation's Fourth Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ present ...
Ultralife(ULBI) - 2023 Q3 - Earnings Call Transcript
2023-10-26 17:42
Ultralife Corporation (NASDAQ:ULBI) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Manna - President & Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Third Quarter 2020 Results Conference Call. All participants are in a listen mode. After the speaker's presentation, t ...
Ultralife(ULBI) - 2023 Q3 - Quarterly Report
2023-10-26 11:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpo ...
Ultralife(ULBI) - 2023 Q2 - Earnings Call Transcript
2023-07-28 02:25
Ultralife Corporation (NASDAQ:ULBI) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Joshua Sullivan - The Benchmark Company Operator Good day and thank you for standing by. Welcome to the Ultralife Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructi ...